IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

RTTNews | 977日前
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

(RTTNews) - Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics as Chief Medical Officer and Head of Research and Development in Oncology.

Beaupre previously served as Senior Vice President, Head of Early Oncology Development and Clinical Research at Pfizer, Inc., where he led cross-disciplinary groups including clinical development, clinical pharmacology, translational oncology and clinical operations related study clinicians.

Beaupre also served at Pharmacyclics (Abbvie) as Vice President, Head of Early Development and Immunotherapy, and at Amgen as Medical Director.

He was previously an Assistant Professor at the H. Lee Moffitt Cancer Center and Research Institute, and also held various earlier appointments at the University of Miami and the M.D. Anderson Cancer Center.

read more
IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews | 528日前
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews | 710日前
China Manufacturing Activity Slips Into Contraction

China Manufacturing Activity Slips Into Contraction

China's factory activity contracted in July as softening new orders forced manufacturers to scale back production and staffing, purchasing managers' survey results from S&P Global showed on Friday. The manufacturing Purchasing Managers' Index fell to 49.5 in July from 50.4 in June. The latest score suggested contraction in the sector.
RTTNews | 11分前
European Economic News Preview: Eurozone Flash Inflation Data Due

European Economic News Preview: Eurozone Flash Inflation Data Due

Flash inflation and final Purchasing Managers' survey data from the euro area are the top economic news due on Friday. At 2.00 am ET, UK Nationwide house price data is due. House prices are forecast to rise 2.1 percent on a yearly basis in July, the same rate as seen in June. At 3.15 am ET, S&P Global publishes Spain's manufacturing PMI data. The index is forecast to rise to 51.7 in July.
RTTNews | 42分前
Australian Market Maintains Early Losses In Mid-market

Australian Market Maintains Early Losses In Mid-market

The Australian stock market is maintaining its early losses in mid-market moves on Friday, extending the losses in the previous session, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the 8,700 level, with weakness across most sectors led by energy and technology stocks.
RTTNews | 3時17分前
Asian Markets Mixed Amid Tariff Uncertainty

Asian Markets Mixed Amid Tariff Uncertainty

Asian stock markets are trading mixed on Friday, following the broadly negative cues from Wall Street overnight, as uncertainty over US reciprocal tariffs still lingers with less than a day remaining for the crucial deadline for negotiations to reach a trade deal expires. US President Donald Trump's revised tariffs on several countries lacking deals are set to be fixed between 10 and 41 percent.
RTTNews | 3時36分前